South Carolina General Assembly 126th Session, 2025-2026
Bill 4641
Download This Bill in Microsoft Word Format
Indicates Matter Stricken Indicates New Matter
(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)
H. 4641
STATUS INFORMATION
General Bill Sponsors: Reps. Pope, Gilliam, Wooten, Oremus, Chapman, McCravy, B. Newton, Martin, White, Schuessler, Ford, Jordan, M.M. Smith, Robbins, Gatch, Duncan, Lastinger, Ligon, Hixon and Ballentine Companion/Similar bill(s): 4636 Document Path: LC-0352VR26.docx
Introduced in the House on January 13, 2026 Introduced in the Senate on April 30, 2026 Last Amended on April 29, 2026 Currently residing in the Senate Committee on Medical Affairs
HISTORY OF LEGISLATIVE ACTIONS
Date
Body
Action Description with journal page number
12/16/2025
House
Prefiled
12/16/2025
House
Referred to Committee on Judiciary
1/13/2026
House
Introduced and read first time (House Journal-page 44)
1/13/2026
House
Referred to Committee on Judiciary (House Journal-page 44)
1/20/2026
House
Member(s) request name added as sponsor: White
1/21/2026
House
Member(s) request name added as sponsor: Schuessler
2/11/2026
House
Member(s) request name added as sponsor: Ford, Jordan, M.M. Smith, Robbins, Gatch
3/4/2026
House
Member(s) request name added as sponsor: Duncan
3/25/2026
House
Member(s) request name added as sponsor: Lastinger
4/15/2026
House
Committee report: Favorable with amendment Judiciary (House Journal-page 4)
4/21/2026
House
Member(s) request name added as sponsor: Ligon, Hixon
4/21/2026
House
Amended (House Journal-page 26)
4/21/2026
House
Requests for debate-Rep(s). McCravy, Duncan, Beach, Cromer, Gilreath, Edgerton, Long, Burns, Ford (House Journal-page 28)
4/23/2026
House
Debate adjourned (House Journal-page 172)
4/29/2026
House
Member(s) request name added as sponsor: Ballentine
4/29/2026
House
Amended (House Journal-page 156)
4/29/2026
House
Read second time (House Journal-page 156)
4/29/2026
House
Roll call Yeas-87 Nays-7 (House Journal-page 171)
4/30/2026
House
Read third time and sent to Senate (House Journal-page 126)
4/30/2026
House
Roll call Yeas-98 Nays-4 (House Journal-page 126)
4/30/2026
Senate
Introduced and read first time (Senate Journal-page 7)
4/30/2026
Senate
Referred to Committee on Medical Affairs (Senate Journal-page 7)
View the latest legislative information at the website
VERSIONS OF THIS BILL
12/17/2025 04/15/2026 04/21/2026 04/29/2026
Indicates Matter Stricken
25 párrafos sin cambios
Indicates New Matter
Amended
April 29, 2026
H. 4641
Introduced by Reps. Pope, Gilliam, Wooten, Oremus, Chapman, McCravy, B. Newton, Martin, White, Schuessler, Ford, Jordan, M. M. Smith, Robbins, Gatch, Duncan, Lastinger, Ligon, Hixon and Ballentine
S. Printed 4/29/26--H.
Read the first time January 13, 2026
________
A bill
TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY AMENDING SECTION 44-53-190, RELATING TO SCHEDULE I CONTROLLED SUBSTANCES, SO AS TO ADD KRATOM TO THE CONTROLLED SUBSTANCES LISTED IN SCHEDULE I; AND BY REPEALING ARTICLE 20 OF CHAPTER 53, TITLE 44 RELATING TO THE SOUTH CAROLINA KRATOM CONSUMER PROTECTION ACT.
Amend Title To Conform
Be it enacted by the General Assembly of the State of South Carolina:
SECTION 1. Section 44-53-2020(A) of the S.C. Code is amended to read:
(A) It is unlawful for a kratom processor or kratom retailer to:
(1) distribute, dispense, or sell any kratom product to any individual under twenty-one years of age; or
(2) prepare, manufacture, distribute, dispense, or sell any kratom product that:
(a) is adulterated with a dangerous non-kratom substance that affects the quality or strength of the product to such a degree that it may injure a consumer;
(b) contains a poisonous or otherwise harmful non-kratom ingredient including, but not limited to, any substance listed in Section 44-53-190, 44-53-210, 44-53-230, 44-53-250, or 44-53-270;
(c) contains a an fully synthetic alkaloid including, but not limited to, fully synthetic mitragynine, fully synthetic 7-hydroxymitragynine, or any other fully synthetically derived compound of the plant mitragyna speciosa;
(d) contains levels of residual solvents higher than the standards set forth in Chapter 467 of the U.S. Pharmacopeia-National Formulary (USP-NF); or
(e) does not meet the labeling requirements established pursuant to Section 44-53-2030 and a regulation promulgated to implement the provisions of that section.
SECTION 2. Section 44-53-190 of the S.C. Code is amended by adding:
(G) Any alkaloid, salt, isomer, compound, derivative, precursor, homologue, analogue, or other preparation thereof, that is substantially chemically equivalent or identical to kratom and including, but not limited to, mitragynine, 7-hydroxymitragynine, or any other synthetically derived compound of the plant mitragyna speciosa.
SECTION 3. This act takes effect upon approval by the Governor.
----XX----
This web page was last updated on April 29, 2026 at 11:32 PM